Jane E. Rogers

2.6k total citations
119 papers, 1.3k citations indexed

About

Jane E. Rogers is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jane E. Rogers has authored 119 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pulmonary and Respiratory Medicine, 57 papers in Oncology and 50 papers in Surgery. Recurrent topics in Jane E. Rogers's work include Gastric Cancer Management and Outcomes (38 papers), Colorectal Cancer Treatments and Studies (21 papers) and Esophageal Cancer Research and Treatment (20 papers). Jane E. Rogers is often cited by papers focused on Gastric Cancer Management and Outcomes (38 papers), Colorectal Cancer Treatments and Studies (21 papers) and Esophageal Cancer Research and Treatment (20 papers). Jane E. Rogers collaborates with scholars based in United States, United Kingdom and Japan. Jane E. Rogers's co-authors include Cathy Eng, Jaffer A. Ajani, Rebecca Waters, Elsa Montgomery, Catherine Pope, Matheus Sewastjanow‐Silva, Arvind Dasari, Robert A. Wolff, George Reed and Kathleen M. Mazor and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and International Journal of Cancer.

In The Last Decade

Jane E. Rogers

108 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane E. Rogers United States 20 499 469 366 194 149 119 1.3k
Brigitte Miller United States 26 744 1.5× 530 1.1× 242 0.7× 167 0.9× 354 2.4× 67 2.0k
Nicola Pavan Italy 21 462 0.9× 456 1.0× 678 1.9× 276 1.4× 82 0.6× 115 1.5k
Melissa K. Frey United States 25 296 0.6× 513 1.1× 142 0.4× 197 1.0× 133 0.9× 147 1.7k
Luigi Frigerio Italy 26 582 1.2× 289 0.6× 188 0.5× 153 0.8× 126 0.8× 88 2.2k
Matthew J. Weiss Canada 22 385 0.8× 501 1.1× 237 0.6× 241 1.2× 148 1.0× 111 1.5k
G.J. Hordijk Netherlands 26 550 1.1× 876 1.9× 666 1.8× 186 1.0× 176 1.2× 73 2.1k
Katherine Van Loon United States 21 270 0.5× 956 2.0× 267 0.7× 201 1.0× 256 1.7× 126 1.7k
Wen Liu‐Mares United States 20 249 0.5× 397 0.8× 251 0.7× 480 2.5× 151 1.0× 33 1.8k
Ly M. Nguyen United States 22 373 0.7× 312 0.7× 472 1.3× 238 1.2× 51 0.3× 50 1.4k
Kerry L. Kilbridge United States 20 368 0.7× 566 1.2× 306 0.8× 152 0.8× 99 0.7× 67 1.2k

Countries citing papers authored by Jane E. Rogers

Since Specialization
Citations

This map shows the geographic impact of Jane E. Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane E. Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane E. Rogers more than expected).

Fields of papers citing papers by Jane E. Rogers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane E. Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane E. Rogers. The network helps show where Jane E. Rogers may publish in the future.

Co-authorship network of co-authors of Jane E. Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of Jane E. Rogers. A scholar is included among the top collaborators of Jane E. Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane E. Rogers. Jane E. Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Covert, Wendy & Jane E. Rogers. (2025). Future Landscape of Anti-Claudin 18.2 Antibodies in Gastric Adenocarcinoma. Antibodies. 14(1). 26–26.
2.
Sewastjanow‐Silva, Matheus, Lianchun Xiao, Graciela M. Nogueras‐González, et al.. (2024). Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study. Cancers. 16(7). 1378–1378. 1 indexed citations
3.
Yamashita, Kohei, Matheus Sewastjanow‐Silva, Katsuhiro Yoshimura, et al.. (2024). SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel. Cancers. 16(7). 1300–1300. 1 indexed citations
4.
Rogers, Jane E. & Jaffer A. Ajani. (2024). Evidence to Date on the Therapeutic Potential of Zolbetuximab in Advanced Gastroesophageal Adenocarcinoma. Current Oncology. 31(2). 769–777. 3 indexed citations
5.
Rogers, Jane E., Cheuk Hong Leung, Van Du Nguyen, et al.. (2024). Direct Clinical Pharmacist-Patient Telephone Follow-Up: A Focus on GI Medical Oncology Symptom Management. JCO Oncology Practice. 20(6). 808–815. 1 indexed citations
6.
Surana, Rishi, Graciela Nogueras González, Jane E. Rogers, et al.. (2023). Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical Trials. Journal of Gastrointestinal Cancer. 54(4). 1308–1315. 1 indexed citations
7.
Murphy, Mariela A. Blum, Graciela M. Nogueras‐González, Matheus Sewastjanow‐Silva, et al.. (2023). Phase I trial of perioperative chemotherapy plus immunotherapy in localized esophageal and gastroesophageal adenocarcinoma.. Journal of Clinical Oncology. 41(4_suppl). 400–400. 1 indexed citations
8.
McNamara, Sara, et al.. (2023). 2474. Emergence of Candida auris in Michigan. Open Forum Infectious Diseases. 10(Supplement_2).
9.
Rogers, Jane E. & Jaffer A. Ajani. (2023). Recent advances in the management of gastric adenocarcinoma patients. PubMed. 12. 2–2. 3 indexed citations
10.
Rogers, Jane E., Michael Leung, Van K. Morris, et al.. (2023). Hepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative Approach. Cancers. 15(15). 3890–3890. 1 indexed citations
11.
Rogers, Jane E., Hyunsoo Hwang, Wei Qiao, et al.. (2022). Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience. The Oncologist. 27(11). 952–957. 14 indexed citations
12.
Leung, Michael, Jane E. Rogers, & Imad Shureiqi. (2021). Use of Uridine Triacetate to Reverse Severe Persistent Myelosuppression Following 5-fluorouracil Exposure in a Patient With a c.557A>G Heterozygous DPYD Variant. Clinical Colorectal Cancer. 20(3). 273–278. 8 indexed citations
13.
Eng, Cathy, Emerson Y. Chen, Jane E. Rogers, et al.. (2021). Moving Beyond the Momentum: Innovative Approaches to Clinical Trial Implementation. JCO Oncology Practice. 17(10). 607–614. 6 indexed citations
14.
Rogers, Jane E., Michael Lam, Daniel M. Halperin, et al.. (2021). Fluorouracil, Doxorubicin with Streptozocin and Subsequent Therapies in Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 112(1). 34–42. 12 indexed citations
15.
Rogers, Jane E. & Arvind Dasari. (2021). Pharmacotherapy for unresectable metastatic colorectal cancer. Expert Opinion on Pharmacotherapy. 23(2). 211–220. 1 indexed citations
16.
Rogers, Jane E., Lianchun Xiao, Fatemeh G. Amlashi, et al.. (2019). Ramucirumab and Paclitaxel Administered Every 2 Weeks (mRAINBOW Regimen) in Advanced Gastroesophageal Adenocarcinoma. Oncology. 96(5). 252–258. 4 indexed citations
17.
Eng, Cathy & Jane E. Rogers. (2018). Current synthetic pharmacotherapy for treatment-resistant colorectal cancer: when urgent action is required. Expert Opinion on Pharmacotherapy. 20(5). 523–534. 4 indexed citations
18.
Rogers, Jane E., Asif Rashid, Khaled M. Elsayes, et al.. (2017). Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy. Journal of Gastrointestinal Oncology. 8(2). 347–351. 34 indexed citations
19.
Elimova, Elena, Xuemei Wang, Elba Etchebehere, et al.. (2015). 18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients. European Journal of Cancer. 51(17). 2545–2552. 47 indexed citations
20.
Harden, Ronald M., et al.. (1979). Doctors accept a challenge: self-assessment exercises in continuing medical education.. BMJ. 2(6191). 652–653. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026